Positive high-level results from a prespecified interim analysis of the I CAN Phase III trial showed that Ultomiris (ravulizumab) met its primary ...
Ukraine has downed 26 Russian Kh-47M2 Kinzhal aeroballistic missiles in the first three months of 2026 thanks to the deployment of the Lima, an electronic warfare system, in a number of oblasts.
Neuropathic pain (NP) has long been considered to arise primarily from abnormal neuronal excitability and ion channel dysfunction. However, accumulating evidence indicates that structural and ...
C3G and IC-MPGN can be difficult to diagnose because they are so rare and their symptoms are vague and nonspecific. A kidney biopsy is considered the gold standard and usually needed to confirm the ...
The prevailing assumption in AI development has been straightforward: larger models trained on more data produce better results. Nvidia's latest release directly challenges that size assumption — and ...
File - The British National Health Service resident doctors hold placards outside St. Thomas' Hospital in London, as medical residents in England begin a five-day strike after talks with the ...
UTC approves a settlement for Cascade to pay up to $2 million after deadly 2023 LNG fire. Investigation finds failures in equipment securing, contractor oversight and more. Settlement mandates ...
The complement system plays a crucial role in immune regulation and inflammatory response and is believed to be involved in the onset and progression of ischemic stroke. Therefore, we aimed to ...
Hundreds of miles from China’s populous coastline, a sharp bend in a remote Himalayan river is set to become the centerpiece of one of the country’s most ambitious – and controversial – infrastructure ...
In 2019 I wrote about research suggesting anti-inflammatory medications might help some people with major depression. At the time, the idea that depression could have roots in the immune system felt ...
The complement system is an innate immune response that leads to increased inflammation. The drug pegcetacoplan—a complement inhibitor—was approved for medical use in the United States in 2021 to ...